Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology: Cutting-edge breakthroughs in immune co-culture killing models

Author:

InnoModels Biotechnology

Release time:

2024-01-10

InnoModels Biotechnology has always been committed to driving innovation in the field of cancer treatment and leading the way in immunotherapy. The company's latest immune co-culture killing model is not only a technological breakthrough, but also provides researchers with an experimental platform that is closer to the physiological context in vivo, which helps to understand the mechanism of immune cell-tumor cell interactions, and provides critical support for the development of personalized treatment plans.
Features of the model
1. 3D tissue simulation:
The new immune co-culture killing model constructs a more realistic three-dimensional tissue structure through precise cell culture technology, simulating the complex interactions between immune cells and tumour cells in vivo. This helps to more accurately predict the effects of therapeutic drugs in vivo.
2. Participation of multiple cell types:
Different from the traditional immune model, the model can simultaneously introduce multiple immune cell types, such as natural killer cells (NK cells), T cells, etc., to simulate a more complex immune response process, so that the experimental results are more biologically meaningful.
3. Visualisation technology support:
Using advanced microscopy techniques and imaging analysis, our model is able to provide real-time observation at the cellular level. This visualisation feature enables researchers to intuitively observe the killing process of immune cells, which helps to gain a deeper understanding of the mechanisms of immunotherapy.
4. Biomarker analysis:
The model allows for exhaustive analysis of biomarkers in the immune response, helping researchers to identify potential predictive indicators that provide an important basis for clinical research and the design of therapeutic regimens.

Application Areas
The new immune co-culture killing model has a wide range of applications in cancer therapeutic research, including but not limited to:
Drug screening and evaluation:
Efficiently and accurately assess the immunocidal effect of potential therapeutic drugs.
Mechanistic studies:
In-depth study of the immune response mechanisms involved in different immune cells, revealing the complex interactions between therapeutic drugs and the immune system.
Immune cell engineering:
Optimise the engineering of immune cells to improve their ability to recognise and kill tumour cells.
Personalised therapy:
Tailor the treatment plan based on the immune profile of the patient to improve the individualisation of the treatment.
Conclusion
The launch of the immune co-culture killing model by InnoModels Biotechnology marks an important leap forward in immunotherapy research. We believe that through the widespread application of this model, it will provide a deeper understanding of the future of cancer treatment and a solid scientific foundation for researchers and physicians to develop more effective treatment protocols. InnoModels Biotechnology will continue its efforts to promote innovation in the field of immunotherapy, bringing more hope and possibilities to patients.

InnoModels Biotechnology: Introduction to IC50 Assay Technology

InnoModels Biotechnology: CDC in vitro immune-tumour cell co-culture killing experimental platform

InnoModels Biotechnology: Introduction to IC50 Assay Technology

InnoModels Biotechnology: CDC in vitro immune-tumour cell co-culture killing experimental platform

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License